Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Novartis N Ord (0QLR)

Price 90.00 on 26-04-2024 at 18:15:02
Change -0.50 -0.55%
Buy 92.25
Sell 87.75
Buy / Sell 0QLR Shares
Last Trade: Unknown 444.00 at 89.48849
Day's Volume: 472,106
Last Close: 90.00
Open: 90.17
ISIN: CH0012005267
Day's Range 87.92 - 90.17
52wk Range: 81.45 - 94.15
Market Capitalisation: -
VWAP: 89.58078
Shares in Issue: 2,040m

Recent Trades History Novartis N Ord (0QLR)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 444 89.48849 OTC Trade
18:06:41 - 26-Apr-24
Unknown* 628 89.54997 OTC Trade
17:52:30 - 26-Apr-24
Unknown* 1,789 89.50308 OTC Trade
17:52:10 - 26-Apr-24
Unknown* -9,607 89.50 SI Trade
Correction
16:56:06 - 26-Apr-24
Unknown* 298 89.48896 OTC Trade
17:09:14 - 26-Apr-24
Unknown* 9,607 89.50 SI Trade
16:56:06 - 26-Apr-24
Unknown* 50,000 89.28 OTC Trade
16:50:58 - 26-Apr-24
Unknown* 20,000 89.64 OTC Trade
16:50:59 - 26-Apr-24
Unknown* 11 89.61396 OTC Trade
16:50:35 - 26-Apr-24
Unknown* 1 89.42894 OTC Trade
16:50:35 - 26-Apr-24

Share Price History for Novartis N Ord

Time period:
to
Date Open High Low Close Volume

Share News for Novartis N Ord

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

24th Jul 2019 10:34

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a Read More

Rio Tinto Appoints Novartis Legal Head As General Counsel Executive

1st Jul 2019 09:13

(Alliance News) - Rio Tinto PLC said Monday it has appointed Barbara Levi as group general counsel with effect from January 1, 2020.She will be replacing Philip Richards, who will retire in Read More

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

24th May 2019 09:35

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU Read More

Oxford BioMedica Notes Kymriah Cancer Treatment's Approval In Japan

26th Mar 2019 12:07

LONDON (Alliance News) - Gene and cell therapy firm Oxford BioMedica PLC on Tuesday noted a drug which uses one of its products has been approved in Japan.Oxford BioMedica is the sole of in Read More

Beximco Pharmaceuticals Acquires 14 New Drug Applications From Sandoz

20th Feb 2019 10:25

LONDON (Alliance News) - Bangladeshi pharmaceutical firm Beximco Pharmaceuticals Ltd said on Wednesday it has agreed to acquire a portfolio of eight Abbreviated New Drug Applications from Sandoz a Read More

FTSE 100 Latest
Value8,139.83
Change60.97

Login to your account

Forgot Password?

Not Registered